Skip to main content

Thermo Fisher Scientific Genetic sciences revenue

  • TMO · NYSE
  • Instruments
  • Life Sciences Tools & Services
  • S&P 500
$700.22+0.11%Close 13 Nov 2026

Genetic sciences revenue at Thermo Fisher Scientific came to $702.0M for the quarter to 26 Sep 2026, down 2.5% from a year earlier.

As Thermo Fisher Scientific reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 30 Oct 2026.

By quarter

$663.0MJun 2024$701.0MSep 2024$677.0MMar 2025$679.0MJun 2025$720.0MSep 2025$794.0MDec 2025$655.0MMar 2026$703.0MJun 2026$702.0MSep 2026
Thermo Fisher Scientific Genetic sciences revenue, every reported period
Period endingGenetic sciences revenueChange on a yearFiled
26 Sep 2026$702.0Mdown 2.5%30 Oct 2026
27 Jun 2026$703.0Mup 3.5%31 Jul 2026
28 Mar 2026$655.0Mdown 3.2%1 May 2026
31 Dec 2025$794.0M—26 Feb 2026
27 Sep 2025$720.0Mup 2.7%31 Oct 2025
28 Jun 2025$679.0Mup 2.4%1 Aug 2025
29 Mar 2025$677.0M—2 May 2025
28 Sep 2024$701.0M—1 Nov 2024
29 Jun 2024$663.0M—2 Aug 2024

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Thermo Fisher Scientific: Organic revenue (change on a year) · Remaining performance obligations · Product revenues · Service revenues · Consumables revenue · Instruments revenue · Clinical research revenue · Research and safety market channel revenue · Pharma services revenue · Biosciences revenue · BioProduction revenue · Chromatography and mass spectrometry revenue · Electron microscopy revenue · Laboratory products revenue · Healthcare market channel revenue · Chemical analysis revenue · Clinical diagnostics revenue · ImmunoDiagnostics revenue · Transplant diagnostics revenue · Microbiology revenue · Laboratory Products and Biopharma Services revenue · Life Sciences Solutions revenue · Analytical Instruments revenue · Specialty Diagnostics revenue · financial statements

Every KPI and segment of TMO, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.